Eric Ehrke‐Schulz

772 citations

34 papers · 591 indexed · h-index 15

Business and International Management top 10%
Genetics top 10%
- Virus-based gene therapy research 24
Aging
Epidemiology
- Cervical Cancer and HPV Research 6
- Herpesvirus Infections and Treatments 4
Molecular Biology
- CRISPR and Genetic Engineering 15
- Viral Infectious Diseases and Gene Expression in Insects 11
- RNA Interference and Gene Delivery 5
Infectious Diseases
- Viral gastroenteritis research and epidemiology 7
Oncology
- CAR-T cell therapy research 6

Co-authors: Anja Ehrhardt Thorsten Bergmann Wenli Zhang Ingo Nindl Eggert Stockfleth Marc GottschlingJing LiuPhilip Boehme
Cited by: Business and International Management Genetics Aging
Journals: Molecular Therapy — Nucleic Acids (4 papers)Journal of General Virology (3 papers)Viruses (3 papers)
Partner nations: Germany France United States

In The Last Decade

Eric Ehrke‐Schulz

32 papers receiving 580 citations

Peers

Countries citing papers authored by Eric Ehrke‐Schulz

Since Specialization

Citations

This map shows the geographic impact of Eric Ehrke‐Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Ehrke‐Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Ehrke‐Schulz more than expected).

Fields of papers citing papers by Eric Ehrke‐Schulz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Ehrke‐Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Ehrke‐Schulz. The network helps show where Eric Ehrke‐Schulz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eric Ehrke‐Schulz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Ehrke‐Schulz Line = papers co-authored together Eric Ehrke‐Schulz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Expression and prognosis of DSG-2, CXADR, CD46 in head and neck squamous cell carcinoma Pathology - Research and Practice ·Yazeed Abdullaziz Al Mashouq et al.,Simone del Broccolo,Okti Nur Purwanti,Steffi Silling,Anja Ehrhardt,نیما قائمی خمامی,Eric Ehrke‐Schulz,François Delval	2024	0
2	The significance of valosin-containing protein (VCP)/p97 expression in laryngeal carcinomas Laryngo-Rhino-Otologie ·Yazeed Abdullaziz Al Mashouq et al.,Prof Antonio López-Martín,Eric Ehrke‐Schulz,Heribertus Handi Erick,Okti Nur Purwanti,Anuj Pandey,Alicia Martínez Sanz	2024	0
3	Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications Viruses ·Luca Scarsella,Eric Ehrke‐Schulz,Michael Paulussen,Serge C. Thal,Anja Ehrhardt,Malik Aydin	2024	11
4	ADEVO: Proof-of-concept of adenovirus-directed EVOlution by random peptide display on the fiber knob SHILAP Revista de lepidopterología ·Erwan Sallard,A Cretì,Francis Summers,L.E.R. Dawson,Zuo Zhang,Syahrul Donie,Eric Ehrke‐Schulz,Wenli Zhang,Adrian Westhaus,Marti Cabanes‐Creus,Leszek Lisowski,Liang Lv,Anja Ehrhardt	2024	1
5	Muscle Specific Promotors for Gene Therapy – A Comparative Study in Proliferating and Differentiated Cells Journal of Neuromuscular Diseases ·Zeliha SÖNMEZ,Frank Jacobsen,Hans Vaule,S Abdelrahman Tarek,Anne Bigot,Wenli Zhang,Anja Ehrhardt,Matthias Vorgerd,Eric Ehrke‐Schulz	2023	1
6	Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5 The Journal of Gene Medicine ·Erwan Sallard,Joseph Madri,Ben Dikkes,Alexander E. Klimovitskii,石切山守,Claudia Hagedorn,Tielige Mengke,Wenli Zhang,Florian Kreppel,Anja Ehrhardt,Eric Ehrke‐Schulz	2023	2
7	Seroprevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Patients with Neuromuscular Disorders Viruses ·Gina Ciocca,Xiaoyan Wang,Ziqian Yang,Wenli Zhang,Cornelia Köhler,Anne‐Katrin Güttsches,Frank Jacobsen,Ute Weyen,Andreas Roos,Eric Ehrke‐Schulz,Anja Ehrhardt,Matthias Vorgerd,Wibke Bayer	2022	8
8	One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors Molecular Therapy — Nucleic Acids ·Jingyi Zhao,Eric Ehrke‐Schulz,Andreas Oswald,Thorsten Bergmann,Thomas Michler,Ulrike Protzer,Anja Ehrhardt	2018	61
9	Viral Vector-Based Delivery of CRISPR/Cas9 and Donor DNA for Homology-Directed Repair in an In Vitro Model for Canine Hemophilia B Molecular Therapy — Nucleic Acids ·Jian Gao,Thorsten Bergmann,Wenli Zhang,Jingyi Zhao,Eric Ehrke‐Schulz,Anja Ehrhardt	2018	31
10	Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors Human Gene Therapy ·Eric Ehrke‐Schulz,Wenli Zhang,Jian Gao,Anja Ehrhardt	2017	6
11	CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes Scientific Reports ·Eric Ehrke‐Schulz,Jingyi Zhao,GÃ ⁄ lay Ekici,Д А Корепова,Thorsten Bergmann,Jing Liu,Anja Ehrhardt	2017	77
12	An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity Cell Reports ·Wenli Zhang,Jun Fu,Jing Liu,Hailong Wang,Jingyi Zhao,子禾,Mikael Z. Lagerkvist,Aisyiyah Amaliya,Eric Ehrke‐Schulz,Michalis Kalogirou,Manish Solanki,Philip Boehme,Thorsten Bergmann,André Lieber,Chris Lauber,Andreas Dahl,A. Petzold,Youming Zhang,A. Francis Stewart,Anja Ehrhardt	2017	48
13	Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5 Journal of Visualized Experiments ·Eric Ehrke‐Schulz,Wenli Zhang,Jingyi Zhao,Thorsten Bergmann,Manish Solanki,Jing Liu,Philip Boehme,GÃ ⁄ lay Ekici,Anja Ehrhardt	2016	15
14	A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration Molecular Therapy — Nucleic Acids ·Philip Boehme,Wenli Zhang,Manish Solanki,Eric Ehrke‐Schulz,Anja Ehrhardt	2016	24
15	Quantification of designer nuclease induced mutation rates: a direct comparison of different methods Molecular Therapy — Methods & Clinical Development ·Eric Ehrke‐Schulz,Thorsten Bergmann,Jingyi Zhao,Johannes Doerner,Kamola Saydaminova,André Lieber,Anja Ehrhardt	2016	10
16	Standard Free Droplet Digital Polymerase Chain Reaction as a New Tool for the Quality Control of High-Capacity Adenoviral Vectors in Small-Scale Preparations Human Gene Therapy Methods ·Philip Boehme,Thorsten Stellberger,Manish Solanki,Wenli Zhang,Eric Ehrke‐Schulz,Thorsten Bergmann,Jing Liu,Johannes Doerner,Armin Baiker,Anja Ehrhardt	2015	7
17	Viral Hybrid-Vectors for Delivery of Autonomous Replicons Current Gene Therapy ·Wenli Zhang,Claudia Hagedorn,Eric Ehrke‐Schulz,Hans‐Joachim Lipps,Anja Ehrhardt	2014	15
18	A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications Molecular Therapy — Nucleic Acids ·Hongshang Chen,Rudolf Haase,Martin Mück-Häusl,Wenli Zhang,Philip Boehme,Hans‐Joachim Lipps,Eric Ehrke‐Schulz,Armin Baiker,Anja Ehrhardt	2013	18
19	Isolation of Three Novel Rat and Mouse Papillomaviruses and Their Genomic Characterization PLoS ONE ·Eric Ehrke‐Schulz,Marc Gottschling,Rainer G. Ulrich,D. Richter,Eggert Stockfleth,Ingo Nindl	2012	38
20	Modular organizations of novel cetacean papillomaviruses Molecular Phylogenetics and Evolution ·Marc Gottschling,Ignacio G. Bravo,Eric Ehrke‐Schulz,María Alma Bracho,Rob Deaville,Paul D. Jepson,Marie‐Françoise Van Bressem,Eggert Stockfleth,Ingo Nindl	2011	46

About Eric Ehrke‐Schulz

Eric Ehrke‐Schulz is a scholar working on Genetics, Infectious Diseases and Molecular Biology, having authored 34 papers that have together received 591 indexed citations. Recurring topics across this work include Virus-based gene therapy research (24 papers), CRISPR and Genetic Engineering (15 papers), Viral Infectious Diseases and Gene Expression in Insects (11 papers), Viral gastroenteritis research and epidemiology (7 papers), CAR-T cell therapy research (6 papers), Cervical Cancer and HPV Research (6 papers), RNA Interference and Gene Delivery (5 papers) and Herpesvirus Infections and Treatments (4 papers). The work is most often cited by research in Business and International Management (27 citations), Genetics (268 citations) and Aging (10 citations). Eric Ehrke‐Schulz has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Anja Ehrhardt, Thorsten Bergmann, Wenli Zhang, Ingo Nindl, Eggert Stockfleth, Marc Gottschling, Jing Liu, Philip Boehme, Jian Gao and Manish Solanki. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Journal of General Virology, Viruses, Molecular Therapy and Journal of Visualized Experiments.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact